Novo Nordisk A/S
LSE:0QIU
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
288.975
647.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
0QIU Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for
0QIU
is 399.458 DKK
with a low forecast of 274.732 DKK and a high forecast of 571.225 DKK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 0QIU's stock price target?
Price Target
399.458
DKK
According to Wall Street analysts, the average 1-year price target for
0QIU
is 399.458 DKK
with a low forecast of 274.732 DKK and a high forecast of 571.225 DKK.
What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Novo Nordisk A/S's revenue is
12%.
The projected
CAGR
for the next 4 years is
7%.
What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
4%
For the last 13 years the
compound annual growth rate for
Novo Nordisk A/S's operating income is
15%.
The projected
CAGR
for the next 4 years is
4%.
What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Novo Nordisk A/S's net income is
15%.
The projected
CAGR
for the next 4 years is
6%.
